The University of San Francisco

USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
Master's Projects and Capstones

Theses, Dissertations, Capstones and Projects

Summer 8-9-2017

Pursuing Equity in Diabetes Population
Aisha Rawlinson
raneidre@gmail.com

Follow this and additional works at: https://repository.usfca.edu/capstone
Part of the Endocrine System Diseases Commons, Nutritional and Metabolic Diseases
Commons, Other Nursing Commons, and the Public Health and Community Nursing Commons
Recommended Citation
Rawlinson, Aisha, "Pursuing Equity in Diabetes Population" (2017). Master's Projects and Capstones. 593.
https://repository.usfca.edu/capstone/593

This Project/Capstone is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at USF Scholarship: a digital
repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in Master's Projects and Capstones by an authorized administrator
of USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.

Running head: PURSUING EQUITY IN DIABETES POPULATION

Pursuing Equity in Diabetes Population
Aisha L. Rawlinson
University of San Francisco

1

PURSUING EQUITY IN DIABETES POPULATION

2

Abstract
Background
Poor glycemic control (HbA1c >8) overtime leads to microvascular and macrovascular
complications after the first and third years respectively, ultimately resulting in death after five
years (Karter, 2016). Current Kaiser Permanente (KP) data stratified by race, ethnicity, age, and
gender shows a significant disparity gap between Hispanics/Latino and Caucasian populations.
The Pursuing IHI initiative is over a 2-year period completed at a microsystem that is focusing
on health equity practices to reduce disparity gaps.
Project aim
KP Riverside, microsystem selected has a large population of Hispanic/Latino KP members, with
focus on health equity. The project aim is to improve glycemic control (HbA1c< 8) among
Hispanic/Latino diabetes patients by 1% from a baseline of 9.8% to 8.8% per KP Riverside
HEDIS data using best practices created from evaluating the relationship between organizational
leadership and community effects on clinical outcomes by performing a PDSA cycle by Q4
2018. The initiative is a 2-year commitment, budget approval will be required for both 2017 and
2018. A 1% decrease in HbA1C is significant in preventing microvascular and macrovascular
complications in poorly controlled diabetes patients.
Results and Sustainability Plan
The results are the development of the project charter and the implementation plan for beginning
work with this site. Long and short term sustainability plans are needed to support the success of
this project and to integrate the global goal of health equity. The short-term plan includes the
CNL assuming the role of the performance improvement advisor and collaborating with the
inter-professional team to implement the improvement process (AACN, 2013; Harris, Roussel, &
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Thomas, 2017). This includes conducting a quick baseline survey or microsystem assessment to
understand current practices and identify gaps. Long term plan includes on-going assessment of
the microsystem and performance improvement data to demonstrate sustainability and identify
new improvement opportunities.
Keywords: diabetes, health equity, Hispanics, Latinos, costs, diabetes management,
health disparities, and best practice strategies.
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Pursuing Equity in Diabetes Population
Clinical Leadership Theme
The clinical leadership themes identified for this project includes organizational and
systems leadership, risk anticipation, quality improvement and safety, translating and integrating
scholarship into practice, inter-professional collaboration for improving patient and population
health outcomes, the use of informatics, and advocacy (AACN, 2013). The CNL must be
knowledgeable about the microsystem and can lead and influence a multidisciplinary team
(AACN, 2013; AACN 2007). The CNL should understand the crucial role of systems theory in
the assessment, design, delivery, and evaluate health care within complex organizations (AACN
2013; AACN, 2007). In addition, the CNL needs to demonstrate financial knowledge regarding
economic principles and practices, including cost-benefit analysis, budgeting, and strategic
planning, human and other resource management, marketing, and value-based purchasing
(AACN, 2013; AACN 2007).
Statement of the Problem
New Kaiser Permanente (KP) Northern California research endorses the urgency of early
glycemic control for diabetic patients. Evidence suggest that poor glycemic control (HgbA1c >8)
overtime leads to microvascular and macrovascular complications after the first and third years
respectively, ultimately resulting in death after five years (Karter, 2016). Current KP data
stratified by race, ethnicity, age, and gender shows a significant disparity gap between
Hispanics/Latinos and the Caucasian populations. The project will be the extension of this work
to include integration and implementation of health equity across the care continuum with
emphasis on improving HgbA1c control in the Hispanic/Latino population. KP Riverside clinic
treats patients with chronic conditions such as diabetes and hypertension. For the purposes of
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Remote Glucose Monitoring, patients with poor glycemic control defines as HgbA1c > 8 will be
given first considerations during the initial implementation.
Project Overview
The improvement theme is an equity focus for the organization of three components;
leadership, community, and clinical outcomes.
Project aim: To improve glycemic control (HgbA1c< 8) among Hispanic/Latino diabetes
patients by 1% from a baseline of 9.8% to 8.8% per KP Riverside HEDIS data using best
practices created from evaluating the relationship between organizational leadership and
community effect on clinical outcomes by performing a PDSA cycle by Q4 2018.
Global aim: To integrate KP National health equity strategy from macro/mesosystem
perspective to the microsystem level and to reduce health disparity gaps among Hispanic/Latino
diabetic members as evidenced by HEDIS data (refer to project aim) by Q4 2018.
Specific: To improve glycemic control of diabetic patients (HgbA1c < 8). To reduce the
disparities gap by 1% among Hispanic/Latinos patients to 8.8% from a baseline of 9.8% by Q4
2018 by improving language concordance, improving cultural competency training among staff
using KP AIDET tools, provider/patient communication (email vs telephone), community
resources, and assessing health literacy/self- management needs.
A multidisciplinary team is needed based on the stakeholder’s analysis to implement equity.
This team includes:
•

Physicians that serve as Clinical Advisors (national, regional, and local)

•

Physician Leadership (national, regional, and local)

•

Physician champions from Endocrinology and Primary Care

•

A representative for IT (important if technology interventions are developed)
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A Pharmacy leader

•

Leader(s) of Nursing / Panel Management

•

A Labor representative (impact to workflows)

•

A CNL with capacity to provide project management and assist with customizing
workflow, patient education, and training materials for panel managers, physicians and
team members.

•

Support staff (national to assist CNL)

•

MPH intern

•

National Quality Director (to remove barriers and establish initial relationships with
Executive Leadership at national, regional, and local levels)

•

Executive sponsors (national senior leaders that support the work of the Pursuing Equity
initiative)
Literature Review

PICOT Question
In an ambulatory care setting (P), what are the best practices for improving glycemic
control (I) for Hispanic/Latino diabetes patients <8% (O) using the health equity strategy for
long term sustainability (over a one-year period) (T).
Search Strategy
An electronic search was conducted in the months of April, May and June 2017 in the
CINAHL Complete, and Pub Med databases using combinations of the following search terms:
diabetes, health equity, Hispanics, Latinos, costs, diabetes management, health disparities, and
best practice strategies. The search yielded 30 articles. More articles could have been yielded if
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search year was expanded to 2005, as there are limited current applicable studies. Limitations
were set to include English only, research, and publication dates no earlier than 2012. Twelve
articles met search criteria, and six were selected for review. The John Hopkins evidence based
practice research tools (JHEBP) were used to appraise the evidence for this review.
Evidence findings
Literature findings consist of a prevalence based study, 2 randomized control trials
(RCTs), conceptual framework white paper, a systematic literature review of RCTs/cohort
studies, and a consensus/position paper to form the foundation of the diverse body of evidence
used for this project. Additional RCTs and studies were also found and will be used to support
the body of evidence. Current intervention based studies were limited because most studies were
performed prior to 5 years. Clinical practice guidelines and bundles based on health equity and
race/ethnicity were unavailable.
American Diabetes Association (2013) performed a prevalence based study that
combines the demographics of the U.S. population in 2012 with diabetes prevalence,
epidemiological data, health care costs, and economic data to determine health care and lost
productivity costs associated with diagnosed diabetes (ADA, 2013). The authors analyzed the
prevalence of diagnosed diabetes, utilization and costs attributed to diabetes by age group from
18 to over 70 years of age, sex, race/ethnicity, and insurance status using data sources derived
from national surveys, government and commercially insured claims databases. Findings of the
study suggested that 22.3 million people are diagnosed with diabetes in the U.S. The financial
implications of diabetes in the U.S. are staggering totaling approximately $245 billion, which
include $176 billion in direct medical costs and $69 billion in lost productivity (ADA, 2013).
Elderly patients (65 years and above) were found to have the most direct medical costs, while
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indirect costs were mostly absorbed by patients who were 18 to 64 years. Adults with
undiagnosed diabetes and prediabetes were found to have added costs, however, these costs were
not included in this study. The clinical implications of this study measure the economic burden
of diagnosed diabetes in the U.S. Study within the last 5 years and can be used to establish a
business case for the importance of reducing health disparities among Latino patients.
In the conceptual framework paper, the authors suggest the following for measuring
health equity: identifying a reference point from which to measure disparities, measure
disparities in both absolute and relative terms, for relative measures across different health
indicators, express all indicators in terms of adverse events, pairwise comparisons to describe
disparities, and use a summary measure of disparities over time for multiple populations (Wyatt,
Laderman, Botwinick, Mate, & Whittington, 2016). The clinical implications of the white paper
serve as a basis of IHI’s Pursuing Equity initiative with KP, in addition to the continuation of
building upon the triple aim: improving patient care, improving health of populations, and
reducing costs per capita (Wyatt, Laderman, Botwinick, Mate, & Whittington, 2016). The
strengths of the newly developed framework model assist health care organizations to integrate
health equity across care continuum and reduce disparities based on race/ethnicity. The model
will not be formally piloted until 2017 within the healthcare setting, which is a limitation.
Therefore, there are no formal studies that can measure effectiveness and outcomes. An
additional limitation is the setting, which limits generalizability. The model will need to be
tailored to the individual needs of the health care organization (HCO), considering HCO’s size,
race/ethnicity populations served, and disease prevalence.
In the 2 RCTs, both studies measured the use community health workers (CHWs) to
improve HgbA1c outcomes among Hispanic/Latino patients with poorly controlled diabetes as
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defined as HgbA1c >8% (Kenya, Lebron, & Arrechea, 2014; Perez-Escamilla et al., 2015). In
addition to using CHWs to improve glycemic outcomes, Kenya et al. (2014) focused on studying
the relationship of pre/post behaviors of self -monitoring of blood glucose (SMBG); glucometer
use, population characteristics, and personal observations of the researchers (Kenya, Lebron, &
Arrechea, 2014). Both studies concluded significant improvement in HgbA1c outcomes when
using CHWs to support diabetes care among Hispanic/Latino patients with poorly controlled
diabetes (Kenya, Lebron, & Arrechea, 2014; Perez-Escamilla et al., 2015). It was also concluded
that SMBG behaviors were not factors in glycemic control. Clinical implications from both
studies support the importance of the relationship between community and clinical outcomes.
In the systematic review of RCTs and cohort studies paper, the authors measured success
rates of intervention features, which were calculated based on effectiveness in improving
glycosylated hemoglobin (HgbA1c), anthropometrics, physical activity, or diet outcomes
negatively or positively (Gucciardi, Wing-Sheung, Manuel, & Sidani, 2013). A significant
change (p-value 0.05) in outcomes defined success, in the hypothesized direction. The results
showed that five intervention features with positive results: hospital-based interventions, group
interventions, the use of situational problem solving, frequent sessions, and incorporating
dietitians as interventionists. An additional six intervention features had high positive rate
differences (i.e. 50%) on specific outcomes. Findings of the paper suggested different diabetes
self- management education (DSME) interventions may influence broad and specific selfmanagement outcomes for women of African/Caribbean and Hispanic/Latin groups (Gucciardi,
Wing-Sheung, Manuel, & Sidani, 2013). Clinical implications support an emphasis on patientcentered care and suggest that providers can consider options based on DSME intervention
features for its broad and specific impact on outcomes (Gucciardi, Wing-Sheung, Manuel, &
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Sidani, 2013). However, most studies focused on interventions for women of African/Caribbean
descent, limited studies focused on Hispanic/Latino women.
In the consensus/position paper, the authors reviewed e-health strategies for Latino
patients with type 2 diabetes (T2D). Disparities Solutions Center experts developed
recommendations based on current research and modalities available to reduce disparities among
Latino diabetic patients. These strategies included using components of successful traditional
non- IT self-management education programs such as e-health text messaging; merging the
community health worker model and e-health; deployment of tablet technology and the
community health worker model; tailoring e-health interventions to include cultural components
and acculturation (Lopez, Tan-McGrory, Horner, & Betancourt, 2016). Findings of the study
suggest that personalization and standardization of e-health interventions on multiple modalities
will help promote long-term reductions in type 2 diabetes disparities. Prevalence rates among
T2D Latinos continues to rise, e-health strategies will become important in promoting prevention
and self- management behaviors, team based care, and increasing patient
engagement/participation for clinicians (Lopez, Tan-McGrory, Horner, & Betancourt, 2016).
Additional studies found in this paper support the emerging themes from the body of
evidence that include using community resources to promote self-management of diabetes care,
developing best practice strategies around cultural relevance, acculturation, using tools of
technology, and customizing interventions to fit the needs of Hispanic/Latino patients with
poorly controlled diabetes to improve disparity gaps and glycemic outcomes (Bartolome,
Makarem, & Arakelian, 2016; Lopez, Grant, Marceau, Piccolo, & McKinlay, 2016; Lyles,
Ratanawongsa, Bolen, & Samal, 2017; Rawlins, Toscano-Garand, & Graham, 2017). It is also
identified that improving patient outcomes by decreasing disparities is supported by
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organizational leadership (Abdus, Mistry, & Selden, 2015; Adepoju, Preston, & Gonzales, 2015;
Wong, LaVeist, & Sharfstein, 2016).
Rationale
Microsystem Assessment Description
Kaiser Permanente Riverside Medical Center (KP Riverside) Indio clinic treats patients
with chronic conditions such as diabetes and hypertension. For the purposes of this project,
patients with poor glycemic control defines as HgbA1c > 8 will be given consideration. KP
Riverside Indio, the microsystem pilot site chosen has a large population of Hispanic/Latino KP
members, with focus on health equity. This microsystem has already implemented changes using
a health equity lens such as switching from a care management approach to a panel/population
management approach for diabetes care among Hispanic/Latino members. Orr & Davenport
describes the model as being “proactive systems of health care delivery to meet the needs of
populations instead of reacting to exacerbations of illness and acute care needs,” (Orr &
Davenport, 2015). Population health and management is essential to assessing population needs,
and pioneering methods to influence large numbers of people to embrace behavior changes of
health promotion and prevention (Orr & Davenport, 2015).
Quality gap and Alignment with organizational goals
KP National Quality has adopted the 6 IOM aims as a part of the clinical quality strategy
for the organization for 2017. Equity is one of the 6 aims that previously was not given enough
attention and focus within the organization. As previously stated, current KP data indicate
significant disparities gaps among African American and Hispanic/Latino members in diabetes
outcomes with members of the Latino ethnicity lagging far behind other groups (refer to baseline
data in Appendix B: Project charter). Equitable care for diabetes was established as an annual
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incentive performance goal for 2017, given that all populations are below the HEDIS benchmark
of the 90th Significant costs are attributed to diabetes for government and commercially insured
patients that impact the organization in the ways of care delivery, inpatient stays, and medication
resources (ADA, 2013; Fitch, Pyenson, & Iawasaki, 2013). Health equity and reducing
disparities are aligned with KP’s mission and vision to deliver high quality care to its members
and the communities in which the organization serve (KP,’s mission statement, 2017). Senior
leaders committed to incorporating equity from a macrosystem strategy to microsystem
implementation by creating an equity framework that will aid in the process.
ROI
The commitment to IHI was made after budgets for 2017 had been finalized. There will
be 1-2 face to face meetings each year with both IHI and KP Riverside including the IHI Annual
Forum. Most activities are virtual, but some contact is required such as the initial project kickoff
with KP Riverside. Since the initiative is a 2-year commitment, budget approval will be required
for both 2017 and 2018. Request amount for 2017 budget is $43,000, which are estimated travel
costs to the facility (Riverside) and for 2018 budget is $45,000 to include KP hosting a face to
face meeting (refer to Table 2, pg. 13). An additional $8,000 is requested for hiring a contracted
vendor to conduct focus groups of interviewing leaders, managers, and Hispanic/Latino members
at KP Riverside (refer to Table 3, pg. 14). There is a $884.48 variance from 2017 request to 2018
to include covering additional charges of KP hosting a face to face conference in 2018 (65-75
participants) (Penner, 2017). Staff expenses include 1 CNL and 1 MPH summer intern available
for this project (Gould, 2017). For the purposes of this paper, staff expenses are included in the
calculation of total project costs. Given that the funding is limited, the CNL can impact the
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budget by reducing travel costs using video conferencing with the microsystem staff and
managing other overhead expenses to maintain budget costs.
In calculating the ROI, a cost benefit analysis was performed for year one and year two
using a sample size of 220 patients assuming 50% have commercial coverage (n=110) and 50%
have government coverage (n=110). Yearly cost avoidance calculations were derived by
multiplying monthly cost avoidance amount by the number of patients (n=110) x 12 months.
Since Medicare/Medicaid and commercial costs varied, the calculations were added together to
get the sum of $229, 668.80 as the annual cost avoidance total (refer to Table 1, pg. 12). This
amount can also be referred to as the total benefits, which is described as the “total savings or
contributions of program or service” (Penner, 2017). As previously stated, the total costs of the
project are $222, 968.48 for 2 years. The benefits costs ratio show that the project saves
approximately over $2 for every $1 spent (refer to Table 1, pg. 12).

Methodology
IHI Model for Improvement
The IHI Model for Improvement addresses the following questions to incorporate into
this project: what are we trying to accomplish? How will we know that a change is an
improvement? What change can we make that will result in an improvement? (IHI, 2016).
Achieving the Triple aim requires CNLs to become high performing team members who are
experts in improving quality of care, health promotion that affect long-term health, reducing
costs, and ensuring patient satisfaction with innovation in the care delivery setting of the
microsystem (AACN, 2013; Orr & Davenport, 2015).
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In addition, the Pursuing Equity initiative has 5 components to support structural change
and improvement consisting of the following: making health equity a strategic priority,
developing structure and processes to support equity work, deploying specific strategies to
address the multiple determinants of health on which health care organizations can have an
impact, decreasing institutional racism within the organization, and developing partnerships with
community organizations (IHI, 2016). KP is partnering with IHI Pursuing equity initiative (2year period) to address health equity by examining the relationship between organizational
leadership and community on impacting clinical outcomes. A Plan, Do, Study, Act cycle will be
performed to test best practices and interventions with the ambulatory setting.
Project Charter
The project charter is a partnership with KP Riverside Medical Center and consist of the
following stakeholders; CNL/National Program Leader, MPH Intern, Director of Hospital &
Health Plan Oversight and Equitable Care (remove barriers), SCAL Regional Leadership, KP
Riverside Executive Medical Director, KP Riverside Leadership, KP Riverside Nursing
Leadership, Physician & Nursing Leads, Staff Champions, and Program Office Support staff.
Refer to Appendix B: Project Charter for further details.
Change Theory and Conceptual Framework
The conceptual framework of this project is composed of Kotter’s organizational model
of change and Institute of Healthcare Improvement’s Achieving Health Equity: A guide for
Health Care Organizations white paper. The Kotter’s model of change consists of eight phases;
establishing a sense of urgency, creating a guiding coalition, developing a change vision,
communicating the vision for buy in support, empowering broad based action, generating short
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term wins, reinforcing the change, and institutionalized new approaches (Orr & Davenport,
2015). This change theory is highly effective when organizations undergo implementation of
large change that impact processes, structures, and workflows such as the implementation of
electronic medical records and health care management projects (Orr & Davenport, 2015).
Integrating the health equity strategy within KP and reducing disparities require a complete
paradigm shift within the organization that can only be supported by using the Kotter’s change
model.
Family of Measures
Data definitions for measurement are the following: population health, social
determinants of health, health equity, health disparity and health inequity, and health care
disparity. Refer to Appendix B: Project charter for further details.
Measurement Strategy and Data Collection Plan
Both outcome and process measures are needed to track performance improvement and to
study and understand the impact of health equity on clinical outcomes. Samples of metrics
include measuring patient touches, tracking treatment intensification, tracking patient adherence
leadership questionnaire findings, and community needs data. Data will be obtained from
HEIDIs reports, which stratifies by race, ethnicity, age, and gender, and KP internal data reports
(i.e. Health Connect and the Online Personal Action Plan) from a sample of 30 patient records to
establish baseline. After baseline data is collected, 10 patient records will be reviewed for project
measures per week for Q3 2017. Data plan will be reevaluated monthly pending review of
results. Refer to Appendix B: Project Charter for further details.
Changes tested and PDSA cycles
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Expected changes tested to include culturally tailored technology interventions of KP
secured email, texting, and Remote Glucose monitoring tools to improve glycemic control
among Hispanic/Latino type 2 diabetes members. These changes will be implemented after
evaluating leadership focus group findings and community needs assessment data to determine
correlations, if any to clinical outcomes (Lopez, Tan-McGrory, Horner, & Betancourt, 2016).
PDSA cycles will perform a small test of change to determine scope of scalability and spread.
Timeline
The Pursuing IHI initiative is over a 2-year period completed at a microsystem that is
focusing on health equity practices to reduce disparity gaps. For the purposes of this project, a
project charter playbook will be developed by July 30, 2017 outlining next steps of conducting
leadership focus groups, reviewing community needs assessment data, and collaborating with the
microsystem prior to developing interventions to test. Refer to Appendix B: Project Charter for
further details.
Expected Results
Significant changes in improving glycemic control (HgbA1c < 8%) among
Hispanic/Latino members should be shown in the Q1 2018 HEDIS data. Health equity strategy
will be fully hardwired into the microsystem by Q1 2018 as evidenced by not only improvement
in diabetes outcomes, but also spread to colorectal cancer screening (CRC) and hypertension
(HTN) sustainability rates.
Nursing Relevance
Healthcare delivered through an equity lens will not only address disparities, but will
demonstrate financial responsibility by providing customized need based care. Rising health care
costs, income, social determinants, and health status will impact coverage and access challenging
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CNLs to deliver and provide patient care (King & Gerard, 2016). Balancing financial stability
and patient preferences will impact future trends in healthcare (Harris, Roussel, & Thomas,
2017). CNLs can use equity to influence change within the microsystem and participate in
developing health policies that promote the health and well-being of the society (Harris, Roussel,
& Thomas, 2017).
Summary Report
Results
The results are the development of the project charter and the implementation plan for
beginning work with this site. To date, the project continues in the development stage as key
stakeholders are in the process of being selected at the microsystem. Next steps include meeting
with KP Riverside to begin the process of implementing the initial steps of conducting the
leadership focus groups. A planned visit to KP Riverside will be scheduled for later in the year
identified as the first Kick off meeting for this project. A revised microsystem assessment will be
conducted to include equipment needs and checking teleconferencing and virtual capabilities. A
drafted project charter has been developed that will be presented during the first meeting with the
microsystem (Appendix C, pg. 32). A questionnaire was developed and currently being vetted
through a KP researcher for validity.
Sustainability Plan
Long and short term sustainability plans are needed to support the success of this project
and to integrate the global goal of health equity. For the short-term plan, the CNL must assume
the role of the performance improvement advisor and collaborate with the inter-professional
team to implement the improvement process (AACN, 2013; Harris, Roussel, & Thomas, 2017).
This includes conducting a quick baseline survey or microsystem assessment to understand
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current practices and identify gaps. An overview of explaining the importance of quality
improvement and the process with be discussed followed by providing KP Riverside copies of
the literature review. The CNL will then discuss the quality improvement tools within the project
charter such as the driver diagram, process mapping, SWOT analysis, and baseline data to
develop a plan to move forward. The driver diagram is important in developing the aim, primary,
and secondary drivers for the project. After the driver diagram is developed, process mapping
will occur to help progress next steps of the project. A SWOT analysis will assess for barriers
that may potentially impede integrating health equity and improving diabetes outcomes within
the microsystem. Baseline data serves as an initial starting point and assist in developing the
measurement strategy of the project. After baseline data is analyzed, interventions will be created
to be tested in the Plan, Do, Study, Act (PDSA) cycle. The PDSA cycle will determine whether
the specific intervention being tested can be scalable and spread throughout KP Riverside and
potentially beyond. The long-term plan includes on-going assessment of the microsystem and
performance improvement data to demonstrate sustainability and identify new improvement
opportunities.
Conclusion
The value of performing diabetes health equity work is immensely important to
improving clinical outcomes. Social determinants of health (SDH) of race, ethnicity, age, gender,
socio-economic status can impact glycemic control even when health providers assume to be
giving “equal care” to all. Integrating health equity and reducing disparities demonstrate the
commitment of KP executing on its mission and vision to deliver high quality care to its
members and the communities in which the organization serve (KP,’s mission statement, 2017).
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Appendix A: Evaluation Table
Citation

Conceptual
Framework

Design/
Method

Sample/
Setting

ADA, 2013

None

Prevalen
ce based
approach
that
combines
the
demogra
phics of
the U.S.
populatio
n in 201
with
diabetes
prevalen
ce,
epidemio
logical
data,
health
care
costs,
and
economi
c data`

Sources for
data were
derived from
Medicare
standard
analytic files,
national
surveys, and
one of the
largest
claims
databases for
commercially
insured
population in
the U.S.

Variables
Studied and
Their
Definitions
Estimating the
size of the
population
with diabetes;
estimating the
direct medical
costs attributed
to diabetes;
estimating the
indirect cost
attributed to
diabetes to
include lost
work
productivity as
defined by
absenteeism,
presenteeism,
inability to
work, and
reduced
productivity
for those not in
the workforce

Measureme
nt

Data
Analysis

Findings

Appraisal:
Worth to
Practice

Calculation
of diabetes
costs using
diabetes
prevalence,
health care
costs (2012),
economic
data, and
epidemiolog
ical data

The
authors
analyzed
the
prevalen
ce of
diagnose
d
diabetes,
utilizatio
n and
costs
attributed
to
diabetes
by age
group
from 18
to over
70 years
of age,
sex,
race/ethn
icity, and
insurance
status

22.3 million people
are diagnosed with
diabetes in the U.S.
Diabetes costs the
nation a total of
$245 billion, which
include $176
billion in direct
medical costs and
$69 billion in lost
productivity.
Elderly patients (65
yrs. +) have the
most direct medical
costs, while most
indirect costs are
absorbed by 18 to
64 yrs. Adults with
undiagnosed
diabetes and
prediabetes have
added costs, which
are not included.

Strengths:
Measures the
economic
burden of
diagnosed
diabetes in
the U.S.
Study is
within the last
5 years.
Findings can
be used to
establish
business case
for reducing
health
disparities
among Latino
patients.
credible
Limitations:
Limited
stratification
and specifics
based on
race/ethnicity
. Does not
include
patient with
undiagnosed
diabetes.
Feasibility:
Can be
applicable to
all patients
diagnosed
with diabetes
in the U.S.
L V, A.
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Gucciardi
WingSheung
Manuel
Sidani,
(2013)

none

Systemat
ic
literature
review of
10
randomiz
ed
control
trials and
3 cohort
studies

The authors
conducted a
literature
search in six
health
databases for
randomized
controlled
trials and
comparative
studies.

Success rates
of intervention
features were
calculated
based on
effectiveness
in improving
glycosylated
hemoglobin
(HgbA1c),
anthropometric
s, physical
activity, or diet
outcomes.
Calculations of
rate
differences
assessed
whether an
intervention
feature
positively or
negatively
affected an
outcome

38
intervention
features in
relation to
their success
with an
outcome
from 13
RCT/cohort
studies.

24
Intervent
ions were
analyzed
based on
their
success
in
producin
ga
significa
nt change
(p-value
0.05) in
outcomes
, in the
hypothes
ized
direction.
Five
interventi
on
features
had
positive
rate
differenc
es across
at least
three
outcomes
:
hospitalbased
interventi
ons,
group
interventi
ons, the
use of
situation
al
problem
solving,
frequent
sessions,
and
incorpora
ting
dietitians
as
interventi
onists.
Six
interventi
on
features

Different DSME
intervention
features may
influence broad
and specific selfmanagement
outcomes for
women of
African/Caribbean
and Hispanic/Latin
ethnicity.

Strengths:
Emphasis on
patientcentered care,
patients and
care
providers can
consider
options based
on DSME
intervention
features for
its broad and
specific
impact on
outcomes.
Limitations:
8 studies
were
Black/African
based, 5
studies were
Hispanic/Lati
nos, based on
the
availability
and limited
studies for
Hispanic/Lati
nos. Due to
the
heterogeneity
of
populations,
interventions,
and measured
outcomes, the
authors could
not conduct a
metaanalysis.
Feasibility:
Suggested
interventions
would have to
be
customized to
patient’s
needs, health
outcomes,
and
appropriate
health care
setting.
L II, B
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had high
positive
rate
differenc
es (i.e.
50%) on
specific
outcomes
.

Kenya,
Lebron, &
Arrechea
(2014)

Randomized
control trial
within a
larger
randomized
control trial

RCT

117 Hispanic
patients with
a HgbA1c
value > 8%
within 12
months
randomized
to the
intervention
arm of
MHHI, in
whom CHWs
could
conduct both
pre/post
assessments
that had
access to
diabetes care
at Jackson
Memorial
hospital.

Pre/post
behaviors of
Self monitoring of
blood glucose
(SMBG);
glucometer
use, CHWs
interventions,
HgbA1c
outcomes,
population
characteristics,
personal
observations
of the
researchers

Quantitative
measures to
include
demographi
c
characteristi
cs,
glucometer
utilization
using a
questionnair
e. Data from
questionnair
e was then
linked to
HgbA1c
values for
intervention
participants.
Qualitative
measures
included
CHWs
interviews
with
participants
understandin
g perceived
barriers to
the success
of
intervention
participants.

Level of
significa
nce (p<
0.001)
glycemic
control
was
defined
as
HgbA1c
> 8% as
poorly
controlle
d
diabetes

SMBG behaviors
were not associated
with glycemic
control. Significant
improvement of
HgbA1c were
identified using
CHW intervention
non-related to
SMBG behaviors.

Strengths:
Limitations:
Financial
status of
participants
impact
SMBG
behaviors not
studied.
Diabetes selfmanagement
education
was not
assessed prior
to
participation
in study.
Emphasis on
reducing
cardiovascula
r disease risks
in poorly
controlled
diabetes vs
sole diabetes
interest.
Participant
eligibility
criteria and
mix method
approach in
data
collection
with control
group vs
intervention
group.
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Lopez
TanMcGrory
Horner
&
Betancourt
(2016)

none

Consens
us or
Position
Stateme
nt
paper:
Systemat
ically
develope
d
recomme
ndations
based on
research
and
nationall
y
recogniz
ed expert
opinion
that
guides
members
of a
professio
nal
organizat
ion in
decisionmaking
for an
issue of
concern

n/a; review
of effective
e-health
strategies for
type 2
diabetic
Latino
patients

Components
of successful
traditional
non-IT selfmanagement
education
programs; ehealth text
messaging;
merging the
community
health worker
model and ehealth;
deployment of
tablet
technology
and the
community
health worker
model;
tailoring ehealth
interventions
for Latino
populations to
include
cultural
components
and
acculturation

n/a;
Disparities
Solutions
Center
experts
developed
recommenda
tions based
on current
research and
modalities
available to
reduce
disparities
among
Latino
diabetic
patients
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Using
factors
for
personali
zing
technolo
gy based
interventi
ons
combine
d with
culturally
relevant
concepts
to
develop
interventi
ons for ehealth
design
for
Latinos

Computer and
mobile technology
interventions will
need to be more
personalized yet
also standardized
on multiple
modalities to
promote long-term
reductions in type 2
diabetes disparities.
Success of an
intervention
depends on longterm adherence and
consideration for
how best to
facilitate
“treatment” fidelity
while balancing
participation
burden. Prevalence
rates among T2D
Latinos continues
to rise, e-health
strategies will
become important
in promoting
prevention and
self- management
behaviors, team
based care, and
increasing patient
engagement/partici

Feasibility:
While
findings can
be used in
developing
interventions
in the health
equity design
to improve
HgbA1c
among
Hispanic/Lati
nos, this
study would
need to be
replicated
removing the
limitations as
outline to
assess
feasibility.
L I, B
Strengths:
Methods
credible
Limitations:
This is a
position
statement
paper
suggesting
strategies that
can be used
to eliminate
e-health
disparities
among
Latinos with
type 2
diabetes.
Strategies
would need to
be piloted and
studied for
effectiveness.
Generalizabili
ty:
Interventions
suggested in
the study will
need to be
first piloted
and measured
to determine
generalizabili
ty.
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PerezEscamilla
Chhabra
Fernandez
SeguraPerez
VegaLopez
KollannorSamuel
Calle et al,
(2015)

none

Random
Control
Trial
-

211 Latinos
with poorly
controlled
type 2 DM
who attended
a community
based
ambulatory
primary care
clinic
randomly
assigned to a
standard of
health care
(control)
group or
CHW.

Goals for care,
metrics for
success, and
quality
outcomes were
monitored.

Data were
collected at
each
participant’s
home at
baseline, 3,
6, 12, & 18
months by
one of five
community
bilingual
interviewers
not involved
with
healthcare
team and
blinded to
health care
delivery
group
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The
authors
conducte
d
between
group
baseline
comparis
ons for
demogra
phic,
socioeco
nomic,
blood
glycemic
and lipid
levels
and
anthropo
metric
character
istics
using X2
testing to
assess
baseline
group
balance

pation for
clinicians.

L IV, B

Strong impact of a
home- based model
can have on
improving
glycemic control
among highly
impoverished
Latinos when a
community health
worker (CHW) is
involved. 12month long
intervention was
followed by a 6month post
intervention to
measure
sustainability.

Strengths:
Methods
credible
Limitations:
Providerlevel data not
collected,
hard to
discern CHW
and provider
driven
pathways that
may have led
to the
significant
impact on
improved
glycemic
control. Bias
of
implementati
on of CHW
intervention.
Feasibility:
study will
need to be
replicated to
remove data
bias and
include
provider level
data prior to
assessing
scalability
and spread.
L I, B
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Wyatt
Botwinick
Mate
Whittingto
n, 2016

Conceptual
framework
for health
care
organization
to achieve
health equity

White
paper

Inpatient
unit’s
ambulatory
units to
include all
levels of care
consisting of
adults and
pediatrics.

Population
health; social
determinants
of health;
health equity;
health
disparity and
health
inequity;
health care
disparity

The authors
suggest the
following
for
measuring
health
equity:
identifying a
reference
point from
which to
measure
disparities,
measure
disparities in
both
absolute and
relative
terms, for
relative
measures
across
different
health
indicators,
express all
indicators in
terms of
adverse
events,
pairwise
comparisons
to describe
disparities,
and use a
summary
measure of
disparities
over time
for multiple
populations.
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A
positive
increase
of 57.4%
in hand
hygiene
from
January
2012 to
Decembe
r 2012,
however,
data
analysis
was very
limited
and
statistical
significa
nce was
not
measured
.

White paper serves
as a continuation of
building on IHI’s
triple aim:
improving patient
care, improving
health of
populations, and
reducing costs per
capita.

Strengths:
framework
model to
integrate
health equity
into health
care
organizations
and reduce
disparities
based on
race/ethnicity
. Basis of
IHI’s
Pursuing
Equity
initiative with
KP.
Limitations:
Framework
has not been
piloted, no
studies to
determine
effectiveness
and outcomes
Generalizabili
ty:
framework
model will
need to be
tailored to the
individual
needs of the
health care
organization,
considering
HCO’s size,
race/ethnicity
populations
served, and
disease
prevalence
L III, A
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Tables
Table 1
ROI
Years

Total benefits
(TB)

Total costs
(TC)

Net benefit (TBTC)

B/C ratio (TB/TC)

2017

$229, 668.80

$111,040

$118,628.8

$2.06 (for every $1 spent)

2018

$229,668.80

$111,924.48

$117,744.32

$2.05 (for every $1 spent)

*Calculations are based on an estimated sample size of 200 patients. Sample size and ROI may
vary based on actual sample size.
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Table 2
Budget
Years

Equipment

Staff

Estimated
Travel Costs

Focus
Groups

Hosting
Expenses

Total costs

2017

TBD- includes
technology- 4
laptops ($500), 2
teleconferencing
phones ($200),
and a projector
screen and
projector ($500) =
$1200

1 CNL FTE
($159, 344
annual
salary) + 1
MPH
summer
intern for 6
months
($8400) X
0.40 =
$67,000

$35,000 to
include KP
Riverside
staff travel to
IHI for onsite
visits in
Boston and
Philadelphia

$8000
(see
focus
group
table)

n/a refer to
2018

$111,040

$35,000 (see
above for
2017)

n/a refer
to 2017

$10,000 for
KP to host
conference

$111,924.48

$7840

$10,000

$222,964.48
for 2 years

*40% of
time/100=
0.40
2018

N/A- costs should
be minimal if
handled in 2017

1 CNL FTE
($167, 311.2
annual salary
with
expected 1%
increase) x
0.40=
$66,924.48

$1,200

$133,924.48* $70,000

* Staff costs are derived from another budget, but included for paper purposes.
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Table 3
Bid for Focus Groups
Participants

Moderation Costs

Honorarium
costs

Estimated total
costs of focus
groups
Moderation (facilitation Max honorariums Participants +
of
(only paid to
Moderation
questionnaire/discussion those who show
costs +
guide)
up) for 22
Honorarium
participants
costs

2 focus groups = 22
participants (MAX)
Recruiting 11 for 8-9
to show from client
supplied member list
participants=$2640
$2640

$3000

$2200

$7840
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Figures: KPSCAL Regional Data and KP Riverside Data for Diabetes

*

32

PURSUING EQUITY IN DIABETES POPULATION
Appendix A: SWOT Analysis
SWOT analysis
*For the purposes of this project, the SWOT analysis is adapted to analyze the internal and
external variables affecting the project. See below.
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Appendix B: Project Timeline
5/25
Define topic
Aim & Background
Microsystem Assessment
Developing Project
Charter
Review and Analyze
SCAL and Riverside Data
for DM
Conduct focus groups for
data collection
Complete Final Charter
Final Presentation

6/1

6/8

6/15

6/22

6/29

7/6

7/13

7/20

7/27

7/30

8/2
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Appendix C: Pursuing Equity Charter

Pursuing Equity in Diabetes population

Aisha L. Rawlinson
May 21, 2017
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Microsystem Assessment
Kaiser Permanente Riverside Indio Medical Office Building (KP Riverside) clinic treats
patients with chronic conditions such as diabetes and hypertension. For the purposes of this
project, patients with poor glycemic control defines as HgbA1c > 8 will be given considerations.
Professionals
A multidisciplinary team is needed to help implement this improvement project. This
team includes:
•

Physicians that serve as IT Clinical Advisors

•

Physician representatives from Endocrinology and Primary Care

•

A representative for IT

•

A Pharmacy leader

•

Leader(s) of Nursing / Care Management

•

A Labor representative

•

A CNL with capacity to provide project management and assist with customizing

•

workflow, patient education, and training materials for care managers, physicians and
team members.

Project aim: To improve glycemic control (HgbA1c< 8) among Hispanic/Latino diabetes
patients.
Global aim: To integrate KP National health equity strategy from Macro/Mesosystem
perspective to the microsystem level and to reduce health disparity gaps among Hispanic/Latino
patients.
Specific: To improve glycemic control of diabetic patients (HgbA1c < 8). To reduce the
disparities gap by 1% among Hispanic/Latinos patients to 8.8% from a baseline of 9.8% by Q4

PURSUING EQUITY IN DIABETES POPULATION

38

HEDIS data 2018 by improving language concordance, provider/patient communication (email
vs telephone), and using KP AIDET training- Hispanic/Latino patients for staff.
Background:
New Kaiser Permanente (KP) Northern California research endorses the urgency of early
glycemic control for diabetic patients. Evidence suggests that patients with poor glycemic
control one year after diabetes diagnosis had a 58% greater risk of developing microvascular
complications, within 3 years after diagnosis had a 68% greater risk of developing macrovascular
complications, and 5 years’ post diagnosis had a 75% chance of death (Karter, 2016).
Measurement Strategy
Population Criteria: Hispanic/Latino diabetic patients treated at Kaiser Riverside Medical
Office Building in Southern California.
Data Collection Method: Data will be obtained from HEIDIs reports, which stratifies by race,
ethnicity, age, and gender, and KP internal data reports (i.e. Health Connect and the Online
Personal Action Plan) from a sample of 200 patient records to establish baseline. After baseline
data is collected, 25 patient records will be reviewed for project measures per week for Q4 2018.
Data plan will be reevaluated monthly pending review of results.
Data Definitions
Data Element
Health Equity

HgbA1c

Health disparity and health inequity

Definition
Achieving the highest level of health for all people
regardless of race, ethnicity, gender, social
determinants of health, or economic status (Wyatt
et. al, 2016).
A lab value that measure the long-term control of
blood glucose concentrations (over 3-month
period) in diabetic patients
are preventable differences in the burden of
disease, injury, violence, or opportunities to
achieve optimal health that are experienced by
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socially disadvantaged populations (CDC, 2017).
Difference in the health outcomes between groups
within a population. Health inequity are differences
that are systematic, unjust, and avoidable (Wyatt et.
al, 2016).
Racial/ethnic differences defined not from access to
care, clinical needs, preferences, and
appropriateness of intervention (Wyatt et. al, 2016).
Circumstances in which people are born, grow up,
live, work, and age, and the systems put in place to
deal with illness (Wyatt et. al, 2016).
Communities in HCO geographic service area or
the patients seen in their organization (Wyatt et. al,
2016).
Framework for improving communication between
providers and patients using a 5-step behavior
component with emphasis on cultural competence.

Healthcare disparity

Social determinants of health

Population health

KP AIDET Training- Hispanic/Latino patients

Measure Description
Measure
HgbA1c
Disparities gap among
Hispanic/Latinos
diabetic patients

Measure Definition
N=# 200 D=# to be
defined
N= # to be defined
D=# to be defined

Data Collection source
HEIDIs report

Goal
HgbA1c < 8

Data stratifying by
race, ethnicity, gender,
and age

1% decrease

Measures (are in processing of being finalized)
Measure
Outcome

Data Source
HB- A1c rates- HEDIS DATA
to include Race, Ethnicity, Age,
Gender

Target
1% decrease by December 2018

Process

Compliance rates with email vs
telephone
Patient ease of access/language
concordance/communication
Increase utilization rates of
Provider and/or Panel manager’s
time

1% increase with email vs
telephone by December 2018
1% increase by December 2018

Balancing

Goals

Not to increase > 1%
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To decrease the disparities gap among Hispanic/Latinos by 1% KP Riverside by December 2018
clinic that includes the following:
1.
2.
3.
4.
5.
6.

Education of Care Managers/ Clinic Staff using culturally competence tools
Patient setup and education
Assessing health literacy
Using technology modalities
Leadership engagement
Community resources

Sponsors
Regional Quality Leader
Medical Director
Regional IT Lead
National Quality Director

Team
Physician Champions
National Program Leader
Care Manager Educator
Staff champions
Care Managers/Nursing Leadership
Pharmacy Leader
Operational Sponsors- Health plan and Medical
Group
Physician Leadership
IT representative
Nursing Champions

Care Manager Director
Physician Lead
Health plan Senior Leaders
Executive Sponsors- Health plan and Medical
Group
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Driver Diagram
1. Driver Diagram Tool
Primary Drivers

Project Aim:
Decrease

HgbA1c

rates > 8 by 1%

1. Re-education of
staff using KP
AIDET tools
for cultural
competence
2. Collect data
using KP
Health Connect
2.
glucose levels
and HEDIS
3.
data stratified
by race and
ethnicity
3. Encourage and
promote email
message for
follow up
communication.
4. Monitor plan
progress

Secondary Drivers
Develop education
plan with cultural
competence tools

Analysis data from
KP SSC from HC and
HEDIS reviewing glucose
levels and email
communication rates.
Convene team to
design workflow AIDET
training.

PURSUING EQUITY IN DIABETES POPULATION
Process Map Tool
Process Example: Creating leadership focus groups:
Develop leadership
questionnaire and vet to
leadership and researcher
Develop estimated budget
to consider additional costs of
conducting leadership focus
groups for Executive sponsors
approval
Meet and discuss project
Standardize process
charter to include conducting
leadership focus groups with
microsystem and obtain input.
Attend Kick Off meeting
and participate in facilitating
focus groups, if possible. Perform
an updated microsystem
assessment to include equipment
needs of computer access,
teleconferencing tools, and virtual
capabilities.
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Baseline data with run chart

Change Theory
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The theoretical framework of this project is based on Kotter’s model of change and
Deming’s theory of management. In Kotter’s theory, which has eight phases; create urgency,
form a coalition, vision, remove obstacles, build on change, short term wins, and anchor the
change.
Suggested changes to test
Current KP data stratified by race, ethnicity, age, and gender shows a significant
disparity gap between Hispanics/Latinos and the Caucasian populations. Of the 8.3
million members, whose spoken language is known 89.8% speak English, 7.9% speak
Spanish, and 0.7% speak Chinese (KFHP, 2016). Spanish is the most common language
of the 450,000 members who need an interpreter. The demographics of our membership
by race/ethnicity are: 46.1% White (non-Hispanic), 26.7% Hispanic or Latino
(regardless of race), 14.6% Asian or Pacific Islander (non-Hispanic), 10.6% Black or
African American (non-Hispanic), 0.3% American Indian or Alaska Native (nonHispanic), and 1.7% Multiracial (two or more races, non-Hispanic) (KFHP, 2016).
Barriers such as culture, language concordance, resource availability, and
transportation can impact treatment and management of diabetes fo r Hispanics/Latinos.

In partnership with IHI Pursing Equity initiative, my project will focus on
improving HgbA1c control for Spanish speaking patients at one medical office building
at Riverside medical facility in Southern California to reduce health disparity gaps,
ultimately improving patient outcomes (Wyatt, Botwinick, Mate, & Whittington, 2016).
Kotter 8 step change model will serve as the framework for this project. Change
concepts will include the following: Specific change ideas:

44
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Self-management: Identify patients with no self-management goal and add note to
their next scheduled appointment to discuss.

•

Self-management: Connect patients interested in diabetes peer management to
program closest to their work or home in their language.

•

Resource availability: Ask 5 patients their barriers to nutritious foods , transportation,
financial resources.

Project timeline
5/25

6/1

6/8

6/15

6/22

6/29

7/6

7/13

7/20

7/27

7/30

Define topic
Aim & Background
Microsystem Assessment
Develop Project Charter
Review and Analyze
SCAL and Riverside DM
data
Conduct focus groups and
collect findings
Complete Charter
Final Presentation

CNL Role
The CNL’s role will meet the following competencies of implementation, coordination,
translation and integration of practice, and management of the project to assist in the delivery of
Quality Initiatives within the microsystem (Bullock, 2011). The CNL role is also important in
monitoring quality outcomes (AACN, 2013). Organizational and Systems Leadership - the CNL
must demonstrate working knowledge of the healthcare system and its component parts,
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including sites of care, delivery models, payment models, and the roles of health care
professionals, patients, caregivers, and unlicensed professionals (AACN, 2013). The CNL will
assume a leadership role of an inter-professional healthcare team with a focus on the delivery of
patient-centered care and the evaluation of quality and cost-effectiveness across the healthcare
continuum. Use systems theory in the assessment, design, delivery, and evaluation of health care
within complex organizations.
The CNL will exhibit knowledge of business acumen such as economic principles and
practices, including cost-benefit analysis, budgeting, and strategic planning, human and other
resource management, marketing, and value-based purchasing (AACN, 2013; Harris, Roussel, &
Thomas, 2017). The CNL will evaluate the efficacy and utility of evidence-based care delivery
approaches and their outcomes at the microsystem level. Collaboration with healthcare
professionals, including physicians, advanced practice nurses, nurse managers and others, is
essential to the stages of planning, implementing, and evaluating performance improvement
(AACN, 2013; Wyatt, Laderman, Botwinick, Mate, & Whittington, 2016). The CNL will
participate in a shared leadership team to make recommendations for improvement at the microsystem level (AACN, 2013).
Quality Improvement and Safety- The CNL must have a robust knowledge of
performance measures to assess and improve the delivery of evidence-based practices and
promote outcomes that demonstrate delivery of higher-value care. As part of quality
improvement and safety, a comprehensive microsystem assessment is completed to provide the
context for problem identification and action (Harris, Roussel, & Thomas, 2017). Then evidence
from literature is used to design and direct system improvements that address trends in safety and
quality. Quality improvement strategies implemented are based on current evidence, analytics,
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and risk anticipation (AACN, 2013). Safety tools of Failure Mode Effects Analysis (FMEA) and
root cause analysis (RCA) help to anticipate, intervene and decrease risk. Patient handoffs and
transitions of care are evaluated to improve outcomes (AACN, 2013; King & Gerard, 2016).
Lessons Learned
This project has undergone many revisions and steps because it involves translating a key
strategic initiative of the organization into a practice to be implemented at the microsystem. Key
stakeholders and leaders must approve the project at every step, which can be a very consuming
involved process. It is important to scale down goals and tests of changes in the project charter to
have realistic and measurable outcomes. In addition, it is important to select an outpatient clinic
as pilot to implement a small test of change as this will have a major impact on workflow and
process of frontline staff.
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Appendix A: Pursuing Equity in Diabetes Population
Riverside Medical Center Leadership Questionnaire
1. Tell us about your commitment to health equity here at Riverside and why it matters to you (i.e.
personal motivation)?
Probe: Can you tell us about a memorable experience with a member or even a member story
that significantly influenced your drive to achieve health equity?
2. Can you briefly state the different health disparities that exist within your community (Riverside
County)?
3. Why is eliminating health inequities important?
4. As a leader, what actions have you taken to advance health equity here at KP Riverside?
Probe: What did you implement, and what failed?
5. What barriers do you face taking on the responsibility to improve health equity here at the
Riverside County? What successes have you had?
Probe: What valuable lessons have you learned so far when dealing with improving health
equity?
6. What do you think Riverside Medical Center’s next steps/actions are moving forward to advance
health equity?
Alternate set of questions
1. As a leader, what have you done to get Riverside to this point?
2. What traits in your opinion are essential for a leader to possess when trying to advance health
equity at their hospital/organization/MOB?
Focus Group Questions. Source http://barhii.org/download/toolkit/nacdd_he_toolkit.pdf
Managers
1. What is your role here at KP Riverside and how long have you been in your current position? (To
distinguish new managers from old managers)
2. What does health equity mean to you?
3. Can you tell me about some of the work the leadership has been doing to address health
inequities? How do you feel about this work?
4. How is the importance of health equity here at KP Riverside brought into the decision-making
process? Can you give an example?
5. What actions have you taken to advance health equity here at KP Riverside?
6. Do you feel supported by the leadership in your efforts to advancing health equity?
Probe: What tools does the leadership provide for you to achieve this initiative?
7. What tools do you provide for staff to learn and continue developing skills around their role in
addressing health inequities?
Probe: What opportunities exist for staff to provide input into efforts to address health
inequities? Are they encouraged or supported and if so, in what ways?
8. In your opinion, what has worked as far as advancing health equity is concerned and what has
not worked?
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Front Line Staff
1. In your opinion, what has KP Riverside done to advance health equity?
Probe: What does health equity mean to you?
2. How long have you been at Kaiser Permanente?
3. How do you feel your managers and leadership support you in this work?
4. How have you been provided with opportunities to give your input into efforts to address health
inequities? Are they encouraged or supported?
5. What has KP Riverside provided you with to enable you to develop skills around addressing
health inequities?
6. What do you think the leadership needs to do to effectively address health inequity?
Closing statement: As we rap up our interview, please mention any remaining ideas you may have about
KP Riverside’s commitment to addressing health inequities.
Members First, thank them for their continuous loyalty and membership of KP Riverside
1.
2.
3.
4.
5.

How long have you been coming to KP Riverside for care and why did you choose KP Riverside?
What is your relationship like with your care provider?
Do you trust your care provider?
Do you feel like your doctor understands your background and values?
Overall, how satisfied are you with the quality of healthcare you have received here at KP
Riverside? Is the care meeting your needs?

*Developed by Nkechinyelu Agulefo, MPH

PURSUING EQUITY IN DIABETES POPULATION

50

Tables
Table 1
ROI
Years

Total benefits
(TB)

Total costs
(TC)

Net benefit (TBTC)

B/C ratio (TB/TC)

2017

$229, 668.80

$111,040

$118,628.8

$2.06 (for every $1 spent)

2018

$229,668.80

$111,924.48

$117,744.32

$2.05 (for every $1 spent)

*Calculations are based on an estimated sample size of 200 patients. Sample size and ROI may
vary based on true sample size.
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Table 2
Budget
Years

Equipment

Staff

Estimated
Travel Costs

Focus
Groups

Hosting
Expenses

Total costs

2017

TBD- includes
technology- 4
laptops ($500), 2
teleconferencing
phones ($200),
and a projector
screen and
projector ($500) =
$1200

1 CNL FTE
($159, 344
annual
salary) + 1
MPH
summer
intern for 6
months
($8400) X
0.40 =
$67,000

$35,000 to
include KP
Riverside
staff travel to
IHI for onsite
visits in
Boston and
Philadelphia

$8000
(see
focus
group
table)

n/a refer to
2018

$111,040

$35,000 (see
above for
2017)

n/a refer
to 2017

$10,000 for
KP to host
conference

$111,924.48

$7840

$10,000

$222,964.48
for 2 years

*40% of
time/100=
0.40
2018

N/A- costs should
be minimal if
handled in 2017

1 CNL FTE
($167, 311.2
annual salary
with
expected 1%
increase) x
0.40=
$66,924.48

$1,200

$133,924.48* $70,000

* Staff costs are derived from another budget, but included for paper purposes.
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Table 3
Bid for Focus Groups
Participants

Moderation Costs

Honorarium
costs

Estimated total
costs of focus
groups
Moderation (facilitation Max honorariums Participants +
of
(only paid to
Moderation
questionnaire/discussion those who show
costs +
guide)
up) for 22
Honorarium
participants
costs

2 focus groups = 22
participants (MAX)
Recruiting 11 for 8-9
to show from client
supplied member list
participants=$2640
$2640

$3000

$2200

$7840
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Appendix A: SWOT Analysis
SWOT analysis
*For the purposes of this project, the SWOT analysis is adapted to analyze the internal and
external variables affecting the project. See below.
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Appendix B: Project Timeline
5/25
Define topic
Aim & Background
Microsystem Assessment
Developing Project
Charter
Review and Analyze
SCAL and Riverside Data
for DM
Conduct focus groups for
data collection
Complete Final Charter
Final Presentation
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